BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21480732)

  • 1. Nicotine effects on general semantic priming in Parkinson's disease.
    Holmes AD; Copland DA; Silburn PA; Chenery HJ
    Exp Clin Psychopharmacol; 2011 Jun; 19(3):215-23. PubMed ID: 21480732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute nicotine enhances strategy-based semantic processing in Parkinson's disease.
    Holmes AD; Copland DA; Silburn PA; Chenery HJ
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):877-85. PubMed ID: 21281557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of dopamine on semantic activation in Parkinson's disease: evidence from a multipriming task.
    Angwin AJ; Copland DA; Chenery HJ; Murdoch BE; Silburn PA
    Neuropsychology; 2006 May; 20(3):299-306. PubMed ID: 16719623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summation of semantic priming and complex sentence comprehension in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    Brain Res Cogn Brain Res; 2005 Sep; 25(1):78-89. PubMed ID: 15894470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine does not enhance basic semantic priming.
    Holmes AD; Chenery HJ; Copland DA
    Psychopharmacology (Berl); 2010 Aug; 211(3):259-65. PubMed ID: 20552173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semantic and cross-case identity priming in patients with Parkinson's disease.
    Filoteo JV; Friedrich FJ; Rilling LM; Davis JD; Stricker JL; Prenovitz M
    J Clin Exp Neuropsychol; 2003 Jun; 25(4):441-56. PubMed ID: 12911099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease.
    Castner JE; Chenery HJ; Copland DA; Coyne TJ; Sinclair F; Silburn PA
    Brain; 2007 May; 130(Pt 5):1395-407. PubMed ID: 17430981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal nicotine modulates strategy-based attentional semantic processing in non-smokers.
    Holmes AD; Chenery HJ; Copland DA
    Int J Neuropsychopharmacol; 2008 May; 11(3):389-99. PubMed ID: 18047753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of task structure on category priming in patients with Parkinson's disease and in healthy individuals.
    Brown GG; Brown SJ; Christenson G; Williams RE; Kindermann SS; Loftis C; Olsen R; Siple P; Shults C; Gorell JM
    J Clin Exp Neuropsychol; 2002 May; 24(3):356-69. PubMed ID: 11992217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The speed of lexical activation is altered in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):73-85. PubMed ID: 17162724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basal ganglia and semantic engagement: potential insights from semantic priming in individuals with subcortical vascular lesions, Parkinson's disease, and cortical lesions.
    Copland D
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1041-52. PubMed ID: 14738285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semantic activation in Parkinson's disease patients on and off levodopa.
    Angwin AJ; Arnott WL; Copland DA; Haire MP; Murdoch BE; Silburn PA; Chenery HJ
    Cortex; 2009 Sep; 45(8):950-9. PubMed ID: 19356748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nicotine on Parkinson's disease.
    Kelton MC; Kahn HJ; Conrath CL; Newhouse PA
    Brain Cogn; 2000; 43(1-3):274-82. PubMed ID: 10857708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aging and cognitive slowing: example of attentional processes--evaluation procedures and related questions].
    Eusop E; Sebban C; Piette F
    Encephale; 2001; 27(1):39-44. PubMed ID: 11294037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of inhibition in Parkinson's disease: evidence from a lexical decision task.
    Marí-Beffa P; Hayes AE; Machado L; Hindle JV
    Neuropsychologia; 2005; 43(4):638-46. PubMed ID: 15716153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
    Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE
    Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemispheric contributions to semantic activation: a divided visual field and event-related potential investigation of time-course.
    Smith ER; Chenery HJ; Angwin AJ; Copland DA
    Brain Res; 2009 Aug; 1284():125-44. PubMed ID: 19497307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
    Scholtissen B; Verhey FR; Adam JJ; Weber W; Leentjens AF
    Clin Neuropharmacol; 2006; 29(5):276-85. PubMed ID: 16960473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semantic priming in Alzheimer's dementia: evidence for dissociation of automatic and attentional processes.
    Bell EE; Chenery HJ; Ingram JC
    Brain Lang; 2001 Feb; 76(2):130-44. PubMed ID: 11254254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.